The global Ivermectin Tablets market was valued at US$ 565 million in 2025 and is anticipated to reach US$ 711 million by 2032, at a CAGR of 3.4% from 2026 to 2032.

Ivermectin Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ivermectin Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Ivermectin is used to treat river blindness (onchocerciasis), intestinal infection from threadworms (strongyloidiasis), and other kinds of worm infections. Ivermectin is an anthelmintic. It works by interfering with the nerve and muscle functions of worms, by paralyzing and killing them.

Global ivermectin tablet production is projected to reach 1.13 billion tablets by 2025, with an average price of US$0.50 per tablet. Gross profit margins typically range from 25% to 40%.

The upstream of the ivermectin tablet industry chain mainly includes the fermentation and chemical synthesis of the active pharmaceutical ingredient (API) ivermectin, excipients, and pharmaceutical packaging materials. Among these, the cost and quality consistency of the API have the greatest impact on the price and compliance of the finished product. The downstream is the core of the demand side, with applications concentrated in the prevention and treatment of human parasitic diseases, including common parasitic diseases such as intestinal nematode infections, scabies, and head lice. The main usage scenarios are hospitals, primary healthcare institutions, pharmacies, and public health projects. In developing countries and tropical regions, this product is widely included in government or international organization-led disease control programs, characterized by large-scale centralized procurement and long-term stable usage. Downstream users are highly price-sensitive but have strict requirements for supply stability and quality standards. In some mature markets, ivermectin is more often used as a prescription drug or for specific indications, with relatively stable demand but limited growth.

The overall industry development trend is characterized by a differentiated demand structure. Public health and centralized procurement channels maintain large-volume, low-price supply, while retail and hospital sectors focus more on dosage accuracy and compliant labeling. Key driving factors include the long-term presence of parasitic diseases in some regions, the continued advancement of public health prevention and control projects, and improved accessibility of generic drugs. The main obstacles are: patents having expired long ago leading to severe homogenization; intense price competition; stricter regulations on ivermectin's indications in some markets; and public opinion and controversies surrounding its use outside of indications causing fluctuations in demand expectations.

This report delivers a comprehensive overview of the global Ivermectin Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ivermectin Tablets. The Ivermectin Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Tablets) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Ivermectin Tablets market comprehensively. Regional market sizes by Type, by Application, by Dosage Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Ivermectin Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Ivermectin Tablets Market Report

Report Metric	Details
Report Name	Ivermectin Tablets Market
Accounted market size in 2025	US$ 565 million
Forecasted market size in 2032	US$ 711 million
CAGR	3.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	0.2mg 0.5mg 1mg 2mg 3mg 6mg 12mg
Segment by Dosage Form	Plain Tablets Dispersible Tablets Chewable Tablets Enteric-Coated Tablets Sustained-Release Tablets Coated Tablets
Segment by Purity	More than 99% 98%-99% 95%-98%
by Application	Livestock Poultry Pets Wild Animals
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck (MSD), Teva, Orion, Substipharm, Medical Valley Invest, Galenicum Derma, Centrafarm, Laboratorios Liconsa, Vygoris, Exeltis, Zydus UK, Dr. Reddy's Laboratories, Edenbridge Pharmaceuticals, Advagen Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Ivermectin Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Ivermectin Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Ivermectin Tablets Market growing?

Ans: The Ivermectin Tablets Market witnessing a CAGR of 3.4% during the forecast period 2026-2032.

What is the Ivermectin Tablets Market size in 2032?

Ans: The Ivermectin Tablets Market size in 2032 will be US$ 711 million.

Who are the main players in the Ivermectin Tablets Market report?

Ans: The main players in the Ivermectin Tablets Market are Merck (MSD), Teva, Orion, Substipharm, Medical Valley Invest, Galenicum Derma, Centrafarm, Laboratorios Liconsa, Vygoris, Exeltis, Zydus UK, Dr. Reddy's Laboratories, Edenbridge Pharmaceuticals, Advagen Pharma

What are the Application segmentation covered in the Ivermectin Tablets Market report?

Ans: The Applications covered in the Ivermectin Tablets Market report are Livestock, Poultry, Pets, Wild Animals

What are the Type segmentation covered in the Ivermectin Tablets Market report?

Ans: The Types covered in the Ivermectin Tablets Market report are 0.2mg, 0.5mg, 1mg, 2mg, 3mg, 6mg, 12mg

1 Ivermectin Tablets Market Overview

1.1 Product Definition

1.2 Ivermectin Tablets by Type

1.2.1 Global Ivermectin Tablets Market Value by Type: 2025 vs 2032

1.2.2 0.2mg

1.2.3 0.5mg

1.2.4 1mg

1.2.5 2mg

1.2.6 3mg

1.2.7 6mg

1.2.8 12mg

1.3 Ivermectin Tablets by Dosage Form

1.3.1 Global Ivermectin Tablets Market Value by Dosage Form: 2025 vs 2032

1.3.2 Plain Tablets

1.3.3 Dispersible Tablets

1.3.4 Chewable Tablets

1.3.5 Enteric-Coated Tablets

1.3.6 Sustained-Release Tablets

1.3.7 Coated Tablets

1.4 Ivermectin Tablets by Purity

1.4.1 Global Ivermectin Tablets Market Value by Purity: 2025 vs 2032

1.4.2 More than 99%

1.4.3 98%-99%

1.4.4 95%-98%

1.5 Ivermectin Tablets by Application

1.5.1 Global Ivermectin Tablets Market Value by Application: 2025 vs 2032

1.5.2 Livestock

1.5.3 Poultry

1.5.4 Pets

1.5.5 Wild Animals

1.6 Global Ivermectin Tablets Market Size Estimates and Forecasts

1.6.1 Global Ivermectin Tablets Revenue 2021–2032

1.6.2 Global Ivermectin Tablets Sales 2021–2032

1.6.3 Global Ivermectin Tablets Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Ivermectin Tablets Market Competition by Manufacturers

2.1 Global Ivermectin Tablets Sales Market Share by Manufacturers (2021–2026)

2.2 Global Ivermectin Tablets Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Ivermectin Tablets Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Ivermectin Tablets, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Ivermectin Tablets, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Ivermectin Tablets, Product Types and Applications

2.7 Global Key Manufacturers of Ivermectin Tablets, Date of Entry into the Industry

2.8 Global Ivermectin Tablets Market Competitive Situation and Trends

2.8.1 Global Ivermectin Tablets Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Ivermectin Tablets Players Market Share by Revenue

2.8.3 Global Ivermectin Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ivermectin Tablets Market Scenario by Region

3.1 Global Ivermectin Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Ivermectin Tablets Sales by Region: 2021–2032

3.2.1 Global Ivermectin Tablets Sales by Region: 2021–2026

3.2.2 Global Ivermectin Tablets Sales by Region: 2027–2032

3.3 Global Ivermectin Tablets Revenue by Region: 2021–2032

3.3.1 Global Ivermectin Tablets Revenue by Region: 2021–2026

3.3.2 Global Ivermectin Tablets Revenue by Region: 2027–2032

3.4 North America Ivermectin Tablets Market Facts & Figures by Country

3.4.1 North America Ivermectin Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Ivermectin Tablets Sales by Country (2021–2032)

3.4.3 North America Ivermectin Tablets Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ivermectin Tablets Market Facts & Figures by Country

3.5.1 Europe Ivermectin Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Ivermectin Tablets Sales by Country (2021–2032)

3.5.3 Europe Ivermectin Tablets Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ivermectin Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Ivermectin Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Ivermectin Tablets Sales by Region (2021–2032)

3.6.3 Asia Pacific Ivermectin Tablets Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ivermectin Tablets Market Facts & Figures by Country

3.7.1 Latin America Ivermectin Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Ivermectin Tablets Sales by Country (2021–2032)

3.7.3 Latin America Ivermectin Tablets Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ivermectin Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Ivermectin Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Ivermectin Tablets Sales by Country (2021–2032)

3.8.3 Middle East and Africa Ivermectin Tablets Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ivermectin Tablets Sales by Type (2021–2032)

4.1.1 Global Ivermectin Tablets Sales by Type (2021–2026)

4.1.2 Global Ivermectin Tablets Sales by Type (2027–2032)

4.1.3 Global Ivermectin Tablets Sales Market Share by Type (2021–2032)

4.2 Global Ivermectin Tablets Revenue by Type (2021–2032)

4.2.1 Global Ivermectin Tablets Revenue by Type (2021–2026)

4.2.2 Global Ivermectin Tablets Revenue by Type (2027–2032)

4.2.3 Global Ivermectin Tablets Revenue Market Share by Type (2021–2032)

4.3 Global Ivermectin Tablets Price by Type (2021–2032)

5 Segment by Application

5.1 Global Ivermectin Tablets Sales by Application (2021–2032)

5.1.1 Global Ivermectin Tablets Sales by Application (2021–2026)

5.1.2 Global Ivermectin Tablets Sales by Application (2027–2032)

5.1.3 Global Ivermectin Tablets Sales Market Share by Application (2021–2032)

5.2 Global Ivermectin Tablets Revenue by Application (2021–2032)

5.2.1 Global Ivermectin Tablets Revenue by Application (2021–2026)

5.2.2 Global Ivermectin Tablets Revenue by Application (2027–2032)

5.2.3 Global Ivermectin Tablets Revenue Market Share by Application (2021–2032)

5.3 Global Ivermectin Tablets Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Merck (MSD)

6.1.1 Merck (MSD) Company Information

6.1.2 Merck (MSD) Description and Business Overview

6.1.3 Merck (MSD) Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Merck (MSD) Ivermectin Tablets Product Portfolio

6.1.5 Merck (MSD) Recent Developments/Updates

6.2 Teva

6.2.1 Teva Company Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Teva Ivermectin Tablets Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Orion

6.3.1 Orion Company Information

6.3.2 Orion Description and Business Overview

6.3.3 Orion Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Orion Ivermectin Tablets Product Portfolio

6.3.5 Orion Recent Developments/Updates

6.4 Substipharm

6.4.1 Substipharm Company Information

6.4.2 Substipharm Description and Business Overview

6.4.3 Substipharm Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Substipharm Ivermectin Tablets Product Portfolio

6.4.5 Substipharm Recent Developments/Updates

6.5 Medical Valley Invest

6.5.1 Medical Valley Invest Company Information

6.5.2 Medical Valley Invest Description and Business Overview

6.5.3 Medical Valley Invest Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Medical Valley Invest Ivermectin Tablets Product Portfolio

6.5.5 Medical Valley Invest Recent Developments/Updates

6.6 Galenicum Derma

6.6.1 Galenicum Derma Company Information

6.6.2 Galenicum Derma Description and Business Overview

6.6.3 Galenicum Derma Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Galenicum Derma Ivermectin Tablets Product Portfolio

6.6.5 Galenicum Derma Recent Developments/Updates

6.7 Centrafarm

6.7.1 Centrafarm Company Information

6.7.2 Centrafarm Description and Business Overview

6.7.3 Centrafarm Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Centrafarm Ivermectin Tablets Product Portfolio

6.7.5 Centrafarm Recent Developments/Updates

6.8 Laboratorios Liconsa

6.8.1 Laboratorios Liconsa Company Information

6.8.2 Laboratorios Liconsa Description and Business Overview

6.8.3 Laboratorios Liconsa Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Laboratorios Liconsa Ivermectin Tablets Product Portfolio

6.8.5 Laboratorios Liconsa Recent Developments/Updates

6.9 Vygoris

6.9.1 Vygoris Company Information

6.9.2 Vygoris Description and Business Overview

6.9.3 Vygoris Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Vygoris Ivermectin Tablets Product Portfolio

6.9.5 Vygoris Recent Developments/Updates

6.10 Exeltis

6.10.1 Exeltis Company Information

6.10.2 Exeltis Description and Business Overview

6.10.3 Exeltis Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Exeltis Ivermectin Tablets Product Portfolio

6.10.5 Exeltis Recent Developments/Updates

6.11 Zydus UK

6.11.1 Zydus UK Company Information

6.11.2 Zydus UK Description and Business Overview

6.11.3 Zydus UK Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Zydus UK Ivermectin Tablets Product Portfolio

6.11.5 Zydus UK Recent Developments/Updates

6.12 Dr. Reddy's Laboratories

6.12.1 Dr. Reddy's Laboratories Company Information

6.12.2 Dr. Reddy's Laboratories Description and Business Overview

6.12.3 Dr. Reddy's Laboratories Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Dr. Reddy's Laboratories Ivermectin Tablets Product Portfolio

6.12.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.13 Edenbridge Pharmaceuticals

6.13.1 Edenbridge Pharmaceuticals Company Information

6.13.2 Edenbridge Pharmaceuticals Description and Business Overview

6.13.3 Edenbridge Pharmaceuticals Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Edenbridge Pharmaceuticals Ivermectin Tablets Product Portfolio

6.13.5 Edenbridge Pharmaceuticals Recent Developments/Updates

6.14 Advagen Pharma

6.14.1 Advagen Pharma Company Information

6.14.2 Advagen Pharma Description and Business Overview

6.14.3 Advagen Pharma Ivermectin Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Advagen Pharma Ivermectin Tablets Product Portfolio

6.14.5 Advagen Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ivermectin Tablets Industry Chain Analysis

7.2 Ivermectin Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ivermectin Tablets Production Mode & Process Analysis

7.4 Ivermectin Tablets Sales and Marketing

7.4.1 Ivermectin Tablets Sales Channels

7.4.2 Ivermectin Tablets Distributors

7.5 Ivermectin Tablets Customer Analysis

8 Ivermectin Tablets Market Dynamics

8.1 Ivermectin Tablets Industry Trends

8.2 Ivermectin Tablets Market Drivers

8.3 Ivermectin Tablets Market Challenges

8.4 Ivermectin Tablets Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Edenbridge Pharmaceuticals

Dr. Reddy’s Laboratories

Advagen Pharma

Substipharm

Medical Valley Invest

List of Tables

Table 1. Global Ivermectin Tablets Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Ivermectin Tablets Market Value by Dosage Form (US$ Million), 2025 vs 2032

Table 3. Global Ivermectin Tablets Market Value by Purity (US$ Million), 2025 vs 2032

Table 4. Global Ivermectin Tablets Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Ivermectin Tablets Market Competitive Situation by Manufacturers in 2025

Table 6. Global Ivermectin Tablets Sales (K Tablets) of Key Manufacturers (2021–2026)

Table 7. Global Ivermectin Tablets Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Ivermectin Tablets Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Ivermectin Tablets Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Ivermectin Tablets Average Price (US$/Tablet) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Ivermectin Tablets, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Ivermectin Tablets, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Ivermectin Tablets, Product Types and Applications

Table 14. Global Key Manufacturers of Ivermectin Tablets, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Ivermectin Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ivermectin Tablets Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Ivermectin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Ivermectin Tablets Sales by Region (K Tablets), 2021–2026

Table 20. Global Ivermectin Tablets Sales Market Share by Region (2021–2026)

Table 21. Global Ivermectin Tablets Sales by Region (K Tablets), 2027–2032

Table 22. Global Ivermectin Tablets Sales Market Share by Region (2027–2032)

Table 23. Global Ivermectin Tablets Revenue by Region (US$ Million), 2021–2026

Table 24. Global Ivermectin Tablets Revenue Market Share by Region (2021–2026)

Table 25. Global Ivermectin Tablets Revenue by Region (US$ Million), 2027–2032

Table 26. Global Ivermectin Tablets Revenue Market Share by Region (2027–2032)

Table 27. North America Ivermectin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Ivermectin Tablets Sales by Country (K Tablets), 2021–2026

Table 29. North America Ivermectin Tablets Sales by Country (K Tablets), 2027–2032

Table 30. North America Ivermectin Tablets Revenue by Country (US$ Million), 2021–2026

Table 31. North America Ivermectin Tablets Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Ivermectin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Ivermectin Tablets Sales by Country (K Tablets), 2021–2026

Table 34. Europe Ivermectin Tablets Sales by Country (K Tablets), 2027–2032

Table 35. Europe Ivermectin Tablets Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Ivermectin Tablets Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Ivermectin Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Ivermectin Tablets Sales by Region (K Tablets), 2021–2026

Table 39. Asia Pacific Ivermectin Tablets Sales by Region (K Tablets), 2027–2032

Table 40. Asia Pacific Ivermectin Tablets Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Ivermectin Tablets Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Ivermectin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Ivermectin Tablets Sales by Country (K Tablets), 2021–2026

Table 44. Latin America Ivermectin Tablets Sales by Country (K Tablets), 2027–2032

Table 45. Latin America Ivermectin Tablets Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Ivermectin Tablets Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Ivermectin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Ivermectin Tablets Sales by Country (K Tablets), 2021–2026

Table 49. Middle East and Africa Ivermectin Tablets Sales by Country (K Tablets), 2027–2032

Table 50. Middle East and Africa Ivermectin Tablets Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Ivermectin Tablets Revenue by Country (US$ Million), 2027–2032

Table 52. Global Ivermectin Tablets Sales (K Tablets) by Type (2021–2026)

Table 53. Global Ivermectin Tablets Sales (K Tablets) by Type (2027–2032)

Table 54. Global Ivermectin Tablets Sales Market Share by Type (2021–2026)

Table 55. Global Ivermectin Tablets Sales Market Share by Type (2027–2032)

Table 56. Global Ivermectin Tablets Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Ivermectin Tablets Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Ivermectin Tablets Revenue Market Share by Type (2021–2026)

Table 59. Global Ivermectin Tablets Revenue Market Share by Type (2027–2032)

Table 60. Global Ivermectin Tablets Price (US$/Tablet) by Type (2021–2026)

Table 61. Global Ivermectin Tablets Price (US$/Tablet) by Type (2027–2032)

Table 62. Global Ivermectin Tablets Sales (K Tablets) by Application (2021–2026)

Table 63. Global Ivermectin Tablets Sales (K Tablets) by Application (2027–2032)

Table 64. Global Ivermectin Tablets Sales Market Share by Application (2021–2026)

Table 65. Global Ivermectin Tablets Sales Market Share by Application (2027–2032)

Table 66. Global Ivermectin Tablets Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Ivermectin Tablets Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Ivermectin Tablets Revenue Market Share by Application (2021–2026)

Table 69. Global Ivermectin Tablets Revenue Market Share by Application (2027–2032)

Table 70. Global Ivermectin Tablets Price (US$/Tablet) by Application (2021–2026)

Table 71. Global Ivermectin Tablets Price (US$/Tablet) by Application (2027–2032)

Table 72. Merck (MSD) Company Information

Table 73. Merck (MSD) Description and Business Overview

Table 74. Merck (MSD) Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 75. Merck (MSD) Ivermectin Tablets Product

Table 76. Merck (MSD) Recent Developments/Updates

Table 77. Teva Company Information

Table 78. Teva Description and Business Overview

Table 79. Teva Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 80. Teva Ivermectin Tablets Product

Table 81. Teva Recent Developments/Updates

Table 82. Orion Company Information

Table 83. Orion Description and Business Overview

Table 84. Orion Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 85. Orion Ivermectin Tablets Product

Table 86. Orion Recent Developments/Updates

Table 87. Substipharm Company Information

Table 88. Substipharm Description and Business Overview

Table 89. Substipharm Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 90. Substipharm Ivermectin Tablets Product

Table 91. Substipharm Recent Developments/Updates

Table 92. Medical Valley Invest Company Information

Table 93. Medical Valley Invest Description and Business Overview

Table 94. Medical Valley Invest Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 95. Medical Valley Invest Ivermectin Tablets Product

Table 96. Medical Valley Invest Recent Developments/Updates

Table 97. Galenicum Derma Company Information

Table 98. Galenicum Derma Description and Business Overview

Table 99. Galenicum Derma Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 100. Galenicum Derma Ivermectin Tablets Product

Table 101. Galenicum Derma Recent Developments/Updates

Table 102. Centrafarm Company Information

Table 103. Centrafarm Description and Business Overview

Table 104. Centrafarm Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 105. Centrafarm Ivermectin Tablets Product

Table 106. Centrafarm Recent Developments/Updates

Table 107. Laboratorios Liconsa Company Information

Table 108. Laboratorios Liconsa Description and Business Overview

Table 109. Laboratorios Liconsa Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 110. Laboratorios Liconsa Ivermectin Tablets Product

Table 111. Laboratorios Liconsa Recent Developments/Updates

Table 112. Vygoris Company Information

Table 113. Vygoris Description and Business Overview

Table 114. Vygoris Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 115. Vygoris Ivermectin Tablets Product

Table 116. Vygoris Recent Developments/Updates

Table 117. Exeltis Company Information

Table 118. Exeltis Description and Business Overview

Table 119. Exeltis Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 120. Exeltis Ivermectin Tablets Product

Table 121. Exeltis Recent Developments/Updates

Table 122. Zydus UK Company Information

Table 123. Zydus UK Description and Business Overview

Table 124. Zydus UK Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 125. Zydus UK Ivermectin Tablets Product

Table 126. Zydus UK Recent Developments/Updates

Table 127. Dr. Reddy's Laboratories Company Information

Table 128. Dr. Reddy's Laboratories Description and Business Overview

Table 129. Dr. Reddy's Laboratories Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 130. Dr. Reddy's Laboratories Ivermectin Tablets Product

Table 131. Dr. Reddy's Laboratories Recent Developments/Updates

Table 132. Edenbridge Pharmaceuticals Company Information

Table 133. Edenbridge Pharmaceuticals Description and Business Overview

Table 134. Edenbridge Pharmaceuticals Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 135. Edenbridge Pharmaceuticals Ivermectin Tablets Product

Table 136. Edenbridge Pharmaceuticals Recent Developments/Updates

Table 137. Advagen Pharma Company Information

Table 138. Advagen Pharma Description and Business Overview

Table 139. Advagen Pharma Ivermectin Tablets Sales (K Tablets), Revenue (US$ Million), Price (US$/Tablet), and Gross Margin (2021–2026)

Table 140. Advagen Pharma Ivermectin Tablets Product

Table 141. Advagen Pharma Recent Developments/Updates

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Ivermectin Tablets Distributors List

Table 145. Ivermectin Tablets Customers List

Table 146. Ivermectin Tablets Market Trends

Table 147. Ivermectin Tablets Market Drivers

Table 148. Ivermectin Tablets Market Challenges

Table 149. Ivermectin Tablets Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

Table 153. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ivermectin Tablets

Figure 2. Global Ivermectin Tablets Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Ivermectin Tablets Market Share by Type: 2025 & 2032

Figure 4. 0.2mg Product Picture

Figure 5. 0.5mg Product Picture

Figure 6. 1mg Product Picture

Figure 7. 2mg Product Picture

Figure 8. 3mg Product Picture

Figure 9. 6mg Product Picture

Figure 10. 12mg Product Picture

Figure 11. Global Ivermectin Tablets Market Value by Dosage Form (US$ Million), 2021–2032

Figure 12. Global Ivermectin Tablets Market Share by Dosage Form: 2025 vs 2032

Figure 13. Plain Tablets Product Picture

Figure 14. Dispersible Tablets Product Picture

Figure 15. Chewable Tablets Product Picture

Figure 16. Enteric-Coated Tablets Product Picture

Figure 17. Sustained-Release Tablets Product Picture

Figure 18. Coated Tablets Product Picture

Figure 19. Global Ivermectin Tablets Market Value by Purity (US$ Million), 2021–2032

Figure 20. Global Ivermectin Tablets Market Share by Purity: 2025 vs 2032

Figure 21. More than 99% Product Picture

Figure 22. 98%-99% Product Picture

Figure 23. 95%-98% Product Picture

Figure 24. Global Ivermectin Tablets Market Value by Application (US$ Million), 2021–2032

Figure 25. Global Ivermectin Tablets Market Share by Application: 2025 & 2032

Figure 26. Livestock

Figure 27. Poultry

Figure 28. Pets

Figure 29. Wild Animals

Figure 30. Global Ivermectin Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 31. Global Ivermectin Tablets Market Size (US$ Million), 2021–2032

Figure 32. Global Ivermectin Tablets Sales (K Tablets), 2021–2032

Figure 33. Global Ivermectin Tablets Average Price (US$/Tablet), 2021–2032

Figure 34. Ivermectin Tablets Report Years Considered

Figure 35. Ivermectin Tablets Sales Share by Manufacturers in 2025

Figure 36. Global Ivermectin Tablets Revenue Share by Manufacturers in 2025

Figure 37. Top 5 and Top 10 Global Ivermectin Tablets Players: Market Share by Revenue in Ivermectin Tablets in 2025

Figure 38. Ivermectin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 39. Global Ivermectin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 40. North America Ivermectin Tablets Sales Market Share by Country (2021–2032)

Figure 41. North America Ivermectin Tablets Revenue Market Share by Country (2021–2032)

Figure 42. United States Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Canada Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Europe Ivermectin Tablets Sales Market Share by Country (2021–2032)

Figure 45. Europe Ivermectin Tablets Revenue Market Share by Country (2021–2032)

Figure 46. Germany Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. France Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. U.K. Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Italy Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Russia Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Asia Pacific Ivermectin Tablets Sales Market Share by Region (2021–2032)

Figure 52. Asia Pacific Ivermectin Tablets Revenue Market Share by Region (2021–2032)

Figure 53. China Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Japan Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. South Korea Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. India Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Australia Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. China Taiwan Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Southeast Asia Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Latin America Ivermectin Tablets Sales Market Share by Country (2021–2032)

Figure 61. Latin America Ivermectin Tablets Revenue Market Share by Country (2021–2032)

Figure 62. Mexico Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Brazil Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Argentina Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. Middle East and Africa Ivermectin Tablets Sales Market Share by Country (2021–2032)

Figure 66. Middle East and Africa Ivermectin Tablets Revenue Market Share by Country (2021–2032)

Figure 67. Turkey Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 68. Saudi Arabia Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 69. UAE Ivermectin Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 70. Global Sales Market Share of Ivermectin Tablets by Type (2021–2032)

Figure 71. Global Revenue Market Share of Ivermectin Tablets by Type (2021–2032)

Figure 72. Global Ivermectin Tablets Price (US$/Tablet) by Type (2021–2032)

Figure 73. Global Sales Market Share of Ivermectin Tablets by Application (2021–2032)

Figure 74. Global Revenue Market Share of Ivermectin Tablets by Application (2021–2032)

Figure 75. Global Ivermectin Tablets Price (US$/Tablet) by Application (2021–2032)

Figure 76. Ivermectin Tablets Value Chain

Figure 77. Channels of Distribution (Direct Vs Distribution)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions